Медицинские препараты Recordati Ilac Стамбул, Турция
A European Specialty Pharmaceutical Group
growth
RECORDATI FINALIZES ITS ACQUISITION OF FRIK İLAÇ IN TURKEY
Turkey Pharmaceuticals Manufacturing 2014 - Digital Release by Global Business Reports - Issuu
PATIENTS | PEOPLE | PRODUCTS | PERFORMANCE
Медицинские препараты Recordati Ilac Стамбул, Турция
CFA Institute Research Challenge
İş Girişim | Frik İlaç
Recordati S.p.A - About Us > History
Untitled
Recordati Company Profile: Stock Performance & Earnings | PitchBook
CFA Institute Research Challenge
Recordati buys Turkey's Frik Ilac for $130 million - PharmaTimes
RECORDATI: VERY GOOD FIRST HALF 2011 RESULTS. SALES +6.6%. NET INCOME +5.3%
NEWS RELEASE
Recordati S.p.A - About Us > History
Медицинские препараты Recordati Ilac Стамбул, Турция
INTERIM REPORT FIRST NINE MONTHS 2013
ANNUAL REPORT 2012
İş Girişim | Frik İlaç
Untitled
